Critical Lessons From High-Value Oncology Practices | Oncology | JAMA Oncology | JAMA Network
[Skip to Navigation]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 35.153.100.128. Please contact the publisher to request reinstatement.
Audio Author Interview (11:17)
1x
0:00 / 0:00
1.
Institute for Healthcare Improvement. IHI Triple Aim initiative. http://www.ihi.org/engage/initiatives/TripleAim/Pages/default.aspx. Published January 6, 2017. Accessed August 18, 2017.
2.
Cress  RD, Chen  YS, Morris  CR, Chew  H, Kizer  KW.  Underutilization of gene expression profiling for early-stage breast cancer in California.  Cancer Causes Control. 2016;27(6):721-727.PubMedGoogle ScholarCrossref
3.
Ramsey  SD, Fedorenko  C, Chauhan  R,  et al.  Baseline estimates of adherence to American Society of Clinical Oncology/American Board of Internal Medicine Choosing Wisely initiative among patients with cancer enrolled with a large regional commercial health insurer.  J Oncol Pract. 2015;11(4):338-343.PubMedGoogle ScholarCrossref
4.
Potosky  AL, Riley  GF, Lubitz  JD, Mentnech  RM, Kessler  LG.  Potential for cancer related health services research using a linked Medicare-tumor registry database.  Med Care. 1993;31(8):732-748.PubMedGoogle ScholarCrossref
5.
Porter  ME.  What is value in health care?  N Engl J Med. 2010;363(26):2477-2481.PubMedGoogle ScholarCrossref
6.
Blayney  DW, McNiff  K, Eisenberg  PD,  et al.  Development and future of the American Society of Clinical Oncology’s Quality Oncology Practice Initiative (QOPI).  J Clin Oncol. 2014;32(35):3907-3913.PubMedGoogle ScholarCrossref
7.
McNiff  KK, Bonelli  KR, Jacobson  JO.  Quality oncology practice initiative certification program: overview, measure scoring methodology, and site assessment standards.  J Oncol Pract. 2009;5(6):270-276.PubMedGoogle ScholarCrossref
8.
Bradley  EH, Curry  LA, Ramanadhan  S, Rowe  L, Nembhard  IM, Krumholz  HM.  Research in action: using positive deviance to improve quality of health care.  Implement Sci. 2009;4:25.PubMedGoogle ScholarCrossref
9.
Greene  J, Hibbard  JH, Alvarez  C, Overton  V.  Supporting patient behavior change: approaches used by primary care clinicians whose patients have an increase in activation levels.  Ann Fam Med. 2016;14(2):148-154.PubMedGoogle ScholarCrossref
10.
Sinsky  CA, Willard-Grace  R, Schutzbank  AM, Sinsky  TA, Margolius  D, Bodenheimer  T.  In search of joy in practice: a report of 23 high-functioning primary care practices.  Ann Fam Med. 2013;11(3):272-278.PubMedGoogle ScholarCrossref
11.
Curry  LA, Spatz  E, Cherlin  E,  et al.  What distinguishes top-performing hospitals in acute myocardial infarction mortality rates? a qualitative study.  Ann Intern Med. 2011;154(6):384-390.PubMedGoogle ScholarCrossref
12.
Milstein  A, Gilbertson  E.  American medical home runs.  Health Aff (Millwood). 2009;28(5):1317-1326.PubMedGoogle ScholarCrossref
13.
Schnipper  LE, Smith  TJ, Raghavan  D,  et al.  American Society of Clinical Oncology identifies five key opportunities to improve care and reduce costs: the top five list for oncology.  J Clin Oncol. 2012;30(14):1715-1724.PubMedGoogle ScholarCrossref
14.
American Society of Clinical Oncology Institute for Quality. QOPI certified practices. http://www.instituteforquality.org/qcp/certified-practices. Published December 1, 2014. Accessed December 9, 2014.
15.
Forthman  MT, Dove  HG, Wooster  LD.  Episode Treatment Groups (ETGs): a patient classification system for measuring outcomes performance by episode of illness.  Top Health Inf Manage. 2000;21(2):51-61.PubMedGoogle Scholar
16.
Pope  C, Ziebland  S, Mays  N.  Qualitative research in health care: analysing qualitative data.  BMJ. 2000;320(7227):114-116.PubMedGoogle ScholarCrossref
17.
Francis  JJ, Johnston  M, Robertson  C,  et al.  What is an adequate sample size? operationalising data saturation for theory-based interview studies.  Psychol Health. 2010;25(10):1229-1245.PubMedGoogle ScholarCrossref
18.
Kaplan  RS, Haas  DA, Warsh  J.  Adding value by talking more.  N Engl J Med. 2016;375(20):1918-1920.PubMedGoogle ScholarCrossref
19.
McWilliams  JM.  Cost containment and the tale of care coordination.  N Engl J Med. 2016;375(23):2218-2220.PubMedGoogle ScholarCrossref
20.
Rocque  GB, Pisu  M, Jackson  BE,  et al; Patient Care Connect Group.  Resource use and Medicare costs during lay navigation for geriatric patients with cancer.  JAMA Oncol. 2017;3(6):817-825.PubMedGoogle ScholarCrossref
21.
Lee  CT, Doran  DM, Tourangeau  AE, Fleshner  NE.  Perceived quality of interprofessional interactions between physicians and nurses in oncology outpatient clinics.  Eur J Oncol Nurs. 2014;18(6):619-625.PubMedGoogle ScholarCrossref
22.
Malin  JL, Keating  NL.  The cost-quality trade-off: need for data quality standards for studies that impact clinical practice and health policy.  J Clin Oncol. 2005;23(21):4581-4584.PubMedGoogle ScholarCrossref
23.
Neuss  MN, Desch  CE, McNiff  KK,  et al.  A process for measuring the quality of cancer care: the Quality Oncology Practice Initiative.  J Clin Oncol. 2005;23(25):6233-6239.PubMedGoogle ScholarCrossref
24.
Blayney  DW, McNiff  K, Hanauer  D, Miela  G, Markstrom  D, Neuss  M.  Implementation of the Quality Oncology Practice Initiative at a university comprehensive cancer center.  J Clin Oncol. 2009;27(23):3802-3807.PubMedGoogle ScholarCrossref
25.
Berenson  RA, Ginsburg  PB, Christianson  JB, Yee  T.  The growing power of some providers to win steep payment increases from insurers suggests policy remedies may be needed.  Health Aff (Millwood). 2012;31(5):973-981.PubMedGoogle ScholarCrossref
26.
Martin  AB, Hartman  M, Benson  J, Catlin  A; National Health Expenditure Accounts Team.  National health spending in 2014: faster growth driven by coverage expansion and prescription drug spending.  Health Aff (Millwood). 2016;35(1):150-160.PubMedGoogle ScholarCrossref
27.
Saluja  R, McDonald  E, Arciero  VS, Cheng  S, Cheung  MC, Chan  KK.  Examining the relationship between cost of novel oncology drugs and their clinical benefit over time.  J Clin Oncol. 2017;35(15)(suppl):6598. doi:10.1200/JCO.2017.35.15_suppl.6598Google Scholar
28.
Centers for Medicare and Medicaid Services. Oncology Care Model. https://innovation.cms.gov/initiatives/oncology-care/. Published April 10, 2017. Accessed August 8, 2017.
Original Investigation
February 2018

Critical Lessons From High-Value Oncology Practices

Author Affiliations
  • 1Stanford Cancer Institute, Stanford, California
  • 2Clinical Excellence Research Center, Stanford University, Stanford, California
  • 3Now with Stanford Healthcare, Stanford, California
  • 4Hutchinson Institute for Cancer Outcomes Research, Fred Hutchinson Cancer Research Center, Seattle, Washington
  • 5Now with Feinberg School of Medicine, Northwestern University, Chicago, Illinois
JAMA Oncol. 2018;4(2):164-171. doi:10.1001/jamaoncol.2017.3803
Key Points

Question  What are the attributes of “positive deviant” oncology practices that deliver high-quality cancer care at low total cost?

Findings  In this analysis using mixed quantitative and qualitative methods and site visits to 7 US oncology practices with structured interview questionnaires, 13 attributes were identified that likely contributed to high-value cancer care. Five attributes most clearly distinguished oncology practice sites that ranked favorably on value.

Meaning  Attributes of high-value positive deviant oncology practices can be implemented in other care systems and their contribution to value studied.

Abstract

Importance  Cancer care is expensive. Cancer care provided by practice organizations varies in total spending incurred by patients and payers during treatment episodes and in quality of care, and this unnecessary variation contributes to the high cost.

Objective  To use the variation in total spending and quality of care to assess oncology practice attributes distinguishing “high value” that may be tested and adopted by others to produce similar results.

Design, Setting, and Participants  “Positive deviance” was used in this exploratory mixed-methods (quantitative and qualitative) analysis of interview results. To quantify value, oncology practices located near the US Pacific Northwest and Midwest with low mean insurer-allowed spending were identified. Among those, practices with high quality were selected. A team then conducted site visits to interview practice personnel from June 2, 2015, through October 3, 2015, and to probe for attributes of high-value care. A qualitative analysis of their interview results was performed, and a panel of experienced oncologists was convened to review attributes occurring uniquely or frequently in low-spending practices for their contribution to value improvement and ease of implementation. Four positive deviant (ie, low-spending) oncology practices and 3 oncology practices that ranked near the middle of the spending distribution were studied.

Main Outcomes and Measures  Thematic saturation in a qualitative analysis of high-value care attributes.

Results  From the 7 oncology practices studied, 13 attributes within the following 5 themes emerged: treatment planning and goal setting, services supporting the patient journey, technical support and physical layout, care team organization and function, and external context. Five attributes (ie, conservative use of imaging, early discussion of treatment limitations and consequences, single point of contact, maximal use of registered nurses for interventions, and a multicomponent health care system) most sharply distinguished the high-value practice sites. The expert oncologist panel judged 3 attributes (ie, early and normalized palliative care, ambulatory rapid response, and early discussion of treatment limitations and consequences) to carry the highest immediate potential for lowering spending without compromising the quality of care.

Conclusions and Relevance  Oncology practice attributes warranting further testing were identified that may lower total spending for high-quality oncology care.

×